Article info

Download PDFPDF

Extended report
Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan

Authors

  1. Correspondence to Professor Shumpei Yokota, Department of Pediatrics, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-000, Japan; yokotashumpei{at}gmail.com
View Full Text

Citation

Yokota S, Itoh Y, Morio T, et al
Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan

Publication history

  • Received April 20, 2015
  • Revised October 1, 2015
  • Accepted October 3, 2015
  • First published December 7, 2015.
Online issue publication 
August 10, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.